QLT has signed an exclusive option agreement with Mati Therapeutics, granting it a 90-day option to acquire assets related to QLT's punctal plug drug delivery system (PPDS) technology for $500,000. The agreement will allow the company ...
Tags: QLT, Mati Therapeutics, PPDS technology, agreement